Arca
Skip to content

Zio AT ECG Monitoring System

Outpatient Cardiac Telemetry. 510(k) K163512, from iRhythm Technologies, Inc. (San Francisco, CA). Product code QYX, class 2.

As of Nov 17, 2026, K163512 is an FDA 510(k) held by iRhythm Technologies, Inc., substantially equivalent on Jun 2, 2017 after 169 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Jun 2, 2017
  • Review time: 169 days
  • Recalls: 1
  • Cited as a predicate by: 4 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Zio QX ECG Monitoring System is intended to capture, analyze and report symptomatic and asymptomatic cardiac events and continuous electrocardiogram (ECG) information for long-term monitoring. While continuously recording patient ECG, both patient-triggered and automatically detected arrhythmia events are transmitted to a monitoring center for reporting.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

4 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K163512, newest first; each opens FDA's recall record
StartedReasonStatus
Sep 28, 2022Z-0183-2023Ambulatory ECG monitoring system labeling update: 1) Clinically actionable arrhythmia notifications delayed until patient registration is complete; 2) Patches limited to 100 symptomatic and 500 asymptomatic wireless…Open, Classified

Other QYX Clearances

The newest 510(k)s for the same product code; their median review was 291 days; see every QYX device

Record

Type
Traditional
Received
Dec 15, 2016
Review panel
Cardiovascular
Regulation
21 CFR 870.1025

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.